Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | neuropeptide S receptor 1 | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | arachidonate 15-lipoxygenase | Starlite/ChEMBL | No references |
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | arachidonate 5 lipoxygenase | arachidonate 15-lipoxygenase | 662 aa | 590 aa | 23.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | lamin | 0.0033 | 0.0015 | 0.2043 |
Schistosoma mansoni | lamin | 0.0033 | 0.0015 | 0.2043 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0 | 0.0022 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0024 | 0.0007 | 0.0148 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0024 | 0.0007 | 0.0148 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.0002 | 0.0087 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0015 | 0.065 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0561 | 0.0455 | 1 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.0802 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0015 | 0.0568 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0015 | 0.065 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0024 | 0.0007 | 0.5 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0067 | 0.0043 | 0.0529 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0284 | 0.0223 | 1 |
Brugia malayi | Doublecortin family protein | 0.0024 | 0.0007 | 0.0239 |
Onchocerca volvulus | 0.0033 | 0.0015 | 1 | |
Brugia malayi | hypothetical protein | 0.0024 | 0.0007 | 0.0239 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0024 | 0.0007 | 0.5 |
Echinococcus multilocularis | RUN | 0.0024 | 0.0007 | 0.0084 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0014 | 0.0627 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0015 | 0.0568 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0015 | 0.0175 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0015 | 0.0175 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0015 | 0.2043 |
Onchocerca volvulus | 0.0033 | 0.0015 | 1 | |
Schistosoma mansoni | lipoxygenase | 0.0067 | 0.0043 | 1 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0024 | 0.0007 | 0.0148 |
Echinococcus granulosus | RUN | 0.0024 | 0.0007 | 0.0148 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0007 | 0.0324 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0015 | 0.065 |
Brugia malayi | follicle stimulating hormone receptor | 0.0284 | 0.0223 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0015 | 0.0309 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0067 | 0.0043 | 0.0934 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0015 | 0.0309 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0024 | 0.0007 | 0.0084 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0024 | 0.0007 | 0.0084 |
Echinococcus granulosus | neuropeptide s receptor | 0.0561 | 0.0455 | 1 |
Loa Loa (eye worm) | doublecortin family protein | 0.0024 | 0.0007 | 0.0324 |
Echinococcus granulosus | lamin | 0.0033 | 0.0015 | 0.0309 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0561 | 0.0455 | 0.5664 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0007 | 0.0324 |
Mycobacterium tuberculosis | Probable histidinol dehydrogenase HisD (HDH) | 1.2033 | 1 | 0.5 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0007 | 0.0239 |
Mycobacterium ulcerans | histidinol dehydrogenase | 1.2033 | 1 | 0.5 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0024 | 0.0007 | 0.0084 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0561 | 0.0455 | 0.5664 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0015 | 0.0175 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.1413 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.3294 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 5.0119 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.3225 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.